Consainsights logo

Pertussis Vaccine Market Size, Share, Industry Trends and Forecast to 2030

Pertussis Vaccine Market Research Report – Segmented By Region (North America, Europe, Asia-Pacific, Middle-East & Africa, Latin America) – Analysis on Size, Share, Trends, COVID-19 Impact, Competitive Analysis, Growth Opportunities and Key Insights from 2019 to 2030.


  • Published date -30th Jan 2024

  • Formats -PDF, CSV

  • Region -Global

Pertussis Vaccine market share by regions

Pertussis Vaccine market share by regions
Pertussis Vaccine Market Analysis

Pertussis Vaccine Market Size & CAGR

The Pertussis Vaccine market is projected to reach a value of USD 2.5 billion by 2023, with a Compound Annual Growth Rate (CAGR) of 5.7% during the forecast period from 2023 to 2030.

COVID-19 Impact on the Pertussis Vaccine Market

The COVID-19 pandemic has significantly impacted the Pertussis Vaccine market, leading to disruptions in supply chains, decreased vaccination rates, and a heightened focus on vaccine development and distribution.

Pertussis Vaccine Market Dynamics

The Pertussis Vaccine market is driven by increasing awareness about vaccination, government initiatives for immunization programs, and advancements in vaccine technology. However, challenges such as vaccine hesitancy and limited access to healthcare services can hinder market growth.

Segments and Related Analysis of the Pertussis Vaccine market

The Pertussis Vaccine market can be segmented based on technology, product, application, and end-user. Each segment plays a crucial role in shaping the market landscape and meeting the diverse needs of stakeholders.

Pertussis Vaccine market analysis report by Region

Asia Pacific Pertussis Vaccine market report

The Asia Pacific region accounts for a significant share of the Pertussis Vaccine market due to the high prevalence of pertussis in countries like India and China. Government initiatives to increase vaccination coverage are driving market growth in this region.

South America Pertussis Vaccine market report

In South America, countries like Brazil and Argentina are witnessing a growing demand for Pertussis Vaccine due to increased awareness about vaccine-preventable diseases. Market players are expanding their presence in this region to cater to the rising need for vaccines.

North America Pertussis Vaccine market report

North America is a mature market for Pertussis Vaccine, with established healthcare infrastructure and high vaccination rates. Market players in this region focus on research and development to introduce new and improved vaccines to meet evolving healthcare needs.

Europe Pertussis Vaccine market report

Europe is witnessing steady growth in the Pertussis Vaccine market, driven by government-funded immunization programs and collaborations between vaccine manufacturers and healthcare providers. Market players in Europe are investing in innovative vaccine technologies to address pertussis outbreaks effectively.

Middle East and Africa Pertussis Vaccine market report

The Middle East and Africa region face challenges in accessing vaccines due to limited healthcare infrastructure and resources. However, initiatives by international organizations and governments to improve immunization coverage are expected to drive market growth in this region.

Pertussis Vaccine market analysis report by Technology

The Pertussis Vaccine market is segmented by technology, including whole-cell vaccines, acellular vaccines, and combination vaccines. Advancements in vaccine technology play a crucial role in enhancing vaccine efficacy and safety.

Pertussis Vaccine market analysis report by Product

Pertussis Vaccine products include DTaP vaccines, Tdap vaccines, and others. These products cater to different age groups and vaccination schedules, ensuring comprehensive protection against pertussis.

Pertussis Vaccine market analysis report by Application

The application of Pertussis Vaccine extends to routine immunization, outbreak control, and travel vaccination. Each application segment addresses specific healthcare needs and contributes to overall disease prevention and control.

Pertussis Vaccine market analysis report by End-User

End-users of Pertussis Vaccine include hospitals, clinics, vaccination centers, and others. These end-users play a vital role in vaccine administration, monitoring vaccine safety, and promoting vaccine coverage among populations.

Key Growth Drivers and Key Market Players of Pertussis Vaccine market

The growth of the Pertussis Vaccine market is driven by factors such as increasing awareness about the importance of vaccination, government support for immunization programs, and the rising prevalence of pertussis. Key market players in the Pertussis Vaccine market include:

  • GlaxoSmithKline
  • Sanofi Pasteur
  • Pfizer Inc.
  • Merck & Co., Inc.
  • Seqirus Inc.

Pertussis Vaccine market trends and future forecast

The Pertussis Vaccine market is witnessing trends such as the development of novel vaccine formulations, increased investment in vaccine research, and collaborations between vaccine manufacturers and healthcare organizations. The future forecast for the Pertussis Vaccine market remains positive, with opportunities for market growth and innovation.

Recent happenings in the Pertussis Vaccine Market

Recent developments in the Pertussis Vaccine market include the introduction of new pertussis vaccine formulations, collaborations between vaccine manufacturers and research institutions, and initiatives to increase vaccination coverage in high-risk populations.

We're grateful to work with incredible clients.

Datasite
Agilent
Johnson
Bio-Rad
Carl Zeiss
Dywidag
Illumina
LEK Consulting
Shell

Related Industries

    Pertussis Vaccine Market FAQs

    What is the market size of the Pertussis Vaccine?

    The global Pertussis Vaccine market size was valued at $4.47 billion in 2020 and is projected to reach $6.21 billion by 2027, growing at a CAGR of 4.5% during the forecast period.

    What are the key market players or companies in the Pertussis Vaccine industry?

    Some of the key players in the Pertussis Vaccine industry include GlaxoSmithKline, Sanofi Pasteur, Merck & Co., Seqirus, and Pfizer.

    What are the primary factors driving the growth in the Pertussis Vaccine industry?

    The primary factors driving the growth in the Pertussis Vaccine industry include increasing awareness about vaccine-preventable diseases, rising investments in healthcare infrastructure, government initiatives for vaccination programs, and expanding immunization coverage.

    Which region is identified as the fastest-growing in the Pertussis Vaccine?

    Asia-Pacific is identified as the fastest-growing region in the Pertussis Vaccine market, attributed to the increasing population, growing healthcare expenditure, rising awareness about vaccination, and government initiatives for immunization programs.

    Does ConsaInsights provide customized market report data for the Pertussis Vaccine industry?

    Yes, ConsaInsights provides customized market report data for the Pertussis Vaccine industry tailored to the specific requirements and needs of clients, including market trends, forecasts, competitor analysis, and strategic insights.

    What deliverables can I expect from this Pertussis Vaccine market research report?

    You can expect deliverables such as comprehensive market analysis, market segmentation, competitive landscape analysis, regulatory framework assessment, pricing analysis, and strategic recommendations for businesses operating in the Pertussis Vaccine industry.